An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery

• Status: Withdrawn
• Trial end date: 2017-07-27
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study will be to evaluate a standardized, evidence-based protocol versus a conventional approach for the dosing of oxytocin in vaginal delivery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: New York University School of Medicine; NYU Langone Health
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

• Vaginal Delivery

Exclusion Criteria:

• Cesarean Delivery

• Allergy to Oxytocin

• Cardiac Arrhythmia